Compare Neurocrine Biosciences Inc (NBIX) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Sunrun Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Sunrun Inc trades at $11.45 (market cap $2.73B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.4× Sunrun Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | RUN | |
|---|---|---|
Market Cap | $17.40B | $2.73B |
Sector | Health | Technology |
52-Week High | $180.55 | $21.41 |
52-Week Low | $123.10 | $9.07 |
Enterprise Value | $16.49B | $16.92B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
